Parmax Pharma Ltd — Results, 30-05-2025: Result

Parmax Pharma Limited has announced a board meeting to approve the financial results for the quarter and half-year. The company reported a net loss of Rs. 2.09 Cr for the year, narrower than the previous year's loss of Rs. 5.75 Cr. Revenue from operations increased significantly to Rs. 28.20 Cr versus Rs. 11.05 Cr last year. The company incurred Rs. 3.69 Cr as expenditure due to a fire at its manufacturing facility, with insurance claim processes underway but not yet finalized. A Rs. 40 lakh investment was made in a mutual fund in the Managing Director's name, raising compliance concerns.